NFKB1 and Insulin resistance: The ability of aspirin to specifically inhibit the protein inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (IKK-β) and further regulate NF-κB signaling pathway results in attenuated insulin resistance while promoting insulin sensitivity.